help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2004-0991
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moon, S.-D.
Right arrow Articles by Cha, B.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moon, S.-D.
Right arrow Articles by Cha, B.-Y.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*OMIM
*UniGene
*Substance via MeSH
Related Collections
Right arrow Calcium and Bone Metabolism
Right arrow Endocrine Oncology
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 2 878-883
Copyright © 2005 by The Endocrine Society

A Novel IVS2-1G>A Mutation Causes Aberrant Splicing of the HRPT2 Gene in a Family with Hyperparathyroidism-Jaw Tumor Syndrome

Sung-Dae Moon, Jae-Hyun Park, Eun-Min Kim, Ju-Hee Kim, Je-Ho Han, Soon-Jib Yoo, Kun-Ho Yoon, Moo-Il Kang, Kwang-Woo Lee, Ho-Yong Son, Sung-Koo Kang, Se-Jeong Oh, Kyung-Mi Kim, Sung-Joo Kim Yoon, Jae-Gahb Park, Il-Jin Kim, Hio Chung Kang, Soon-Won Hong, Kyung-Rae Kim and Bong-Yun Cha

Departments of Internal Medicine (S.-D.M., J.-H.K., J.-H.H., S.-J.Y., K.-H.Y., M.-I.K., K.-W.L., H.-Y.S., S.-K.K., B.-Y.C.) and Clinical Pathology (K.-M.K.), and Research Institute of Molecular Genetics, Catholic Research Institutes of Medical Science, Department of Biomedical Sciences (E.-M.K., S.-J.K.Y.), The Catholic University of Korea College of Medicine, Seoul, 137-701 Korea; Korean Hereditary Tumor Registry (J.-H.P., J.-G.P., I.-J.K., H.C.K.), Laboratory of Cell Biology, Cancer Research Center and Cancer Research Institute, Seoul National University, Seoul, 151-742 Korea; Research Institute and Hospital (J.-G.P.), National Cancer Center, Goyang, Gyeonggi, 411-769 Korea; Departments of Pathology (S.-W.H.) and Internal Medicine (K.-R.K.), Yonsei University College of Medicine, Seoul, 120-749 Korea; and Departments of Internal Medicine (S.-D.M., J.-H.H.) and Surgery (S.-J.O.), Our Lady of Mercy Hospital, The Catholic University of Korea College of Medicine, Incheon, 403-720 Korea

Address all correspondence and requests for reprints to: Dr. Je-Ho Han, Division of Endocrinology and Metabolism, Department of Internal Medicine, Our Lady of Mercy Hospital, The Catholic University of Korea College of Medicine, 665 Pupyung-dong Pupyung-gu, Incheon 403-720, Korea. E-mail: hjh60103{at}dreamwiz.com.

HRPT2, the gene associated with hyperparathyroidism-jaw tumor (HPT-JT) syndrome, was previously mapped to 1q24-q32. It was recently cloned, and several germline mutations were found to predispose to HPT-JT syndrome. We sequenced the complete HRPT2 coding sequence and splice-junctional regions in a Korean family with HPT-JT syndrome and identified a novel germline mutation, IVS2-1G>A in intron 2, that caused the autosomal dominant trait of HPT-JT syndrome in this family. RT-PCR and sequencing of the transcripts revealed that this splicing mutation generated alternative splicing errors leading to the formation of two different transcripts, one with exon 3 deleted, the other lacking the first 23 bp of exon 3 due to the use of an internal splice acceptor in exon 3. Translation of both transcripts results in premature termination. In addition, we detected two novel somatic mutations of HRPT2 in malignant parathyroid tumors from the affected individuals. One, 85delG, causes premature termination; the other, an 18 bp in-frame deletion of 13_30delCTTAGCGTCCTGCGACAG, suggests that this region may be important in the development of the parathyroid carcinomas in HPT-JT syndrome. These findings provide further evidence that mutation of HRPT2 is associated with the formation of parathyroid tumors in HPT-JT syndrome.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. Ghosh, H. Kuppusamy, and L. M. Pilarski
Aberrant Splice Variants of HAS1 (Hyaluronan Synthase 1) Multimerize with and Modulate Normally Spliced HAS1 Protein: A POTENTIAL MECHANISM PROMOTING HUMAN CANCER
J. Biol. Chem., July 10, 2009; 284(28): 18840 - 18850.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
M. A Hahn, J. McDonnell, and D. J Marsh
The effect of disease-associated HRPT2 mutations on splicing
J. Endocrinol., June 1, 2009; 201(3): 387 - 396.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Adamia, A. A. Reichert, H. Kuppusamy, J. Kriangkum, A. Ghosh, J. J. Hodges, P. M. Pilarski, S. P. Treon, M. J. Mant, T. Reiman, et al.
Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia
Blood, December 15, 2008; 112(13): 5111 - 5121.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
G. Masi, L. Barzon, M. Iacobone, G. Viel, A. Porzionato, V. Macchi, R. De Caro, G. Favia, and G. Palu
Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism
Endocr. Relat. Cancer, December 1, 2008; 15(4): 1115 - 1126.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
F Cetani, E Pardi, E Ambrogini, P Viacava, S Borsari, M Lemmi, L Cianferotti, P Miccoli, A Pinchera, A Arnold, et al.
Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation
Endocr. Relat. Cancer, June 1, 2007; 14(2): 493 - 499.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
V. M. Howell, J. W. Cardinal, A.-L. Richardson, O. Gimm, B. G. Robinson, and D. J. Marsh
Rapid Mutation Screening for HRPT2 and MEN1 Mutations Associated with Familial and Sporadic Primary Hyperparathyroidism
J. Mol. Diagn., November 1, 2006; 8(5): 559 - 566.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V. Guarnieri, A. Scillitani, L. A. Muscarella, C. Battista, N. Bonfitto, M. Bisceglia, S. Minisola, M. L. Mascia, L. D'Agruma, and D. E. C. Cole
Diagnosis of Parathyroid Tumors in Familial Isolated Hyperparathyroidism with HRPT2 Mutation: Implications for Cancer Surveillance
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2827 - 2832.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
C Juhlin, C Larsson, T Yakoleva, I Leibiger, B Leibiger, A Alimov, G Weber, A Hoog, and A Villablanca
Loss of parafibromin expression in a subset of parathyroid adenomas.
Endocr. Relat. Cancer, June 1, 2006; 13(2): 509 - 523.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society